EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Clinical outcomes of linezolid monotherapy vs. combination therapy in vancomycin-resistant enterococcal infections

Prarin Siriwattanakowit, Pakawan Charoensataporn, Tossaroot Theeranuwat, Poramet Sirirat, Nonthapohn Laohakul, Wichai Santimaleeworagun, Dhitiwat Changpradub, Jatapat Hemapanpairoa

Journal of Global Antimicrobial Resistance · 2026-05 · 48 · 121-126

DOI: 10.1016/j.jgar.2026.03.005 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Global Antimicrobial Resistance, 2026-05. Verfasst von Prarin Siriwattanakowit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand. Hauptthemen laut MEDLINE: Linezolid, Anti-Bacterial Agents, Gram-Positive Bacterial Infections, Vancomycin-Resistant Enterococci. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidAnti-Bacterial AgentsGram-Positive Bacterial InfectionsVancomycin-Resistant EnterococciHumansRetrospective StudiesFemaleDrug Therapy, CombinationMaleMiddle AgedAgedTreatment OutcomeHospital MortalityLength of Stay

Stichwörter der Autor:innen

Clinical outcomesCombination therapyHematologic effectsLinezolidVancomycin-resistant Enterococcus

Substanzen

LinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand.
  • Division of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand; Pharmaceutical Initiative for Resistant Bacteria and Infectious Diseases Working Group (PIRBIG), Nakorn Pathom, Thaila…
  • Division of Infectious Diseases, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.
  • Division of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand. Electronic address: jatapathemapanpairoa@gmail.com.

Zitieren

APA

Siriwattanakowit, P., Charoensataporn, P., Theeranuwat, T., Sirirat, P., Laohakul, N., Santimaleeworagun, W., Changpradub, D., & Hemapanpairoa, J. (2026). Clinical outcomes of linezolid monotherapy vs. combination therapy in vancomycin-resistant enterococcal infections. Journal of Global Antimicrobial Resistance, 48, 121-126. https://doi.org/10.1016/j.jgar.2026.03.005

Vancouver

Siriwattanakowit P, Charoensataporn P, Theeranuwat T, Sirirat P, Laohakul N, Santimaleeworagun W, et al. Clinical outcomes of linezolid monotherapy vs. combination therapy in vancomycin-resistant enterococcal infections. Journal of Global Antimicrobial Resistance. 2026;48:121-126. doi:10.1016/j.jgar.2026.03.005

BibTeX
@article{Siriwattanakowit2026,
  author = {Siriwattanakowit, Prarin and Charoensataporn, Pakawan and Theeranuwat, Tossaroot and Sirirat, Poramet and Laohakul, Nonthapohn and Santimaleeworagun, Wichai and Changpradub, Dhitiwat and Hemapanpairoa, Jatapat},
  title = {Clinical outcomes of linezolid monotherapy vs. combination therapy in vancomycin-resistant enterococcal infections},
  journal = {Journal of Global Antimicrobial Resistance},
  year = {2026},
  volume = {48},
  pages = {121--126},
  doi = {10.1016/j.jgar.2026.03.005}
}
Kostenlos starten →